Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 104Multiple Myeloma 66Lymphoma 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Myelodysplastic Syndromes 51Lymphoma, Non-Hodgkin 51Leukemia 50Hodgkin Disease 42Lymphoma, Mantle-Cell 29Lymphoma, Large B-Cell, Diffuse 29Leukemia, Lymphocytic, Chronic, B-Cell 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Lymphoma, Follicular 22Burkitt Lymphoma 22Breast Neoplasms 22Recurrence 20Neoplasms, Plasma Cell 18Neuroblastoma 17Hematologic Neoplasms 17Lymphoma, B-Cell, Marginal Zone 15Myeloproliferative Disorders 14Lymphoma, Large-Cell, Immunoblastic 14Leukemia, Myelomonocytic, Chronic 12Leukemia, Biphenotypic, Acute 12Congenital Abnormalities 12Blast Crisis 10Anemia, Refractory, with Excess of Blasts 10Retinoblastoma 9Central Nervous System Neoplasms 9Sarcoma 8

Interventions

Rituximab 7Pyridostigmine Bromide 5Prednisone 5efgartigimod alfa 4Hizentra 4telitacicept 3Immunoglobulins, Intravenous 3Cyclophosphamide 3Azathioprine 3thymoglobulin 2fludarabine 2Thymectomy 2Steroids 2Mycophenolic Acid 2Data Collection 2Blood Specimen Collection 2zilucoplan 1tofacitinib 1tocilizumab 1talquetamab 1sargramostim 1rozanolixizumab 1prednylidene 1gamma-Globulins 1deltacortene 1carmustine, poliferprosan 20 drug combination 1bu-zhong-yi-qi-tang 1apraclonidine 1Walk Test 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myasthenia Gravis × Granulocyte Colony-Stimulating Factor × Clear all
NCT00424489 2018-08-31

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Northwestern University

Phase 1 Terminated
9 enrolled 8 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡